Purpose To assess the short-term and long-term comparative efficacy and safety of ASMs for
Lennox-Gastaut syndrome (LGS). Methods Following a systematic literature search …

Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy but there is limited
literature characterizing the disease burden despite this being crucial for disease …

Aim To compare and rank the efficacy and safety of antiseizure medication (ASM) in patients
with Lennox–Gastaut syndrome (LGS). Method We included randomized controlled trials …

Anti‐seizure medications for Lennox‐Gastaut syndrome - Brigo, F - 2021 | Cochrane Library
Skip to Content Cookies Our site uses cookies to improve your experience. You can find out …

ABSTRACT Introduction Lennox-Gastaut syndrome (LGS) is a severe childhood-onset
epileptic encephalopathy, characterized by multiple seizure types, generalized slow spike …

Introduction Rufinamide is an antiseizure medication that acts through sodium channels and
is found to be efficacious in patients with Lennox Gastaut syndrome (LGS). However, no …

Abstract Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and
epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group of …

Lennox‐Gastaut syndrome (LGS) is an intractable childhood‐onset epileptic
encephalopathy. Seizure freedom is rare in LGS. One of the hallmarks of LGS is medical …

Abstract Background Lennox Gastaut Syndrome (LGS) is an epilepsy syndrome presenting
in childhood, classically characterised by a triad of cognitive or developmental impairment …

Lennox–Gastaut syndrome (LGS) is a severe epileptic and developmental encephalopathy
that is associated with a high rate of morbidity and mortality. It is characterized by multiple …